Clinical Trial Opens for Extending Migraine Treatment to Children

Share

TwitterFacebookCopy LinkPrintEmail

STAMFORD — The New England Institute for Clinical Research is partnering with New-Haven based Biohaven Pharmaceuticals to recruit participants in a clinical trial to study whether a drug used to trea...

Haven’t subscribed yet? Click here to register.

CT Examiner is just $20 a year. And if you want to unsubscribe? That’s online and at the click of a button. No phone calls. No runaround. No hassle.

At less than a tenth the cost of our statewide competitors, our promise to you is no-nonsense federal, state, and local news that’s nonpartisan, respects your privacy and is ad-free.

Subscribe and see why CT Examiner is the fastest growing news source in Connecticut.


Emilia Otte

Emilia Otte covers health and education for the Connecticut Examiner. In 2022 Otte was awarded "Rookie of the Year," by the New England Newspaper & Press Association.

e.otte@ctexaminer.com